Eisai Co. Ltd. has climbed aboard the PROTAC research bandwagon gathering speed in the pharma industry globally, signing a new academic research collaboration targeting novel drug discovery in the burgeoning field.
The Japanese firm will work with the team of Alessio Ciulli, a global pioneer on proteolysis-targeting chimeras (PROTACs) at the...



![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

